General Updates

National Stock Exchange of India Ltd. Exchange Plaza, C 1, Block G, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051. Company Symbol: QMSMEDI ISIN: INE0FMW01018 Sub: Achievement of Gold Certification in Cybersecurity Assessment by QMS Medical Allied Services Ltd We wish to inform the Exchange that QMS Medical Allied Services Ltd ("the Company") has successfully completed a comprehensive cybersecurity assessment conducted by CyberVadis, a globally recognised third-party cybersecurity risk-rating and assessment platform, and has been awarded the "Gold" certification for the year 2026. The Company scored 918 out of 1000 in the assessment, placing it in the "Mature" cybersecurity maturity category. The certification is valid until 17 August 2027, following which a re-assessment will be undertaken in the ordinary course. About the CyberVadis Assessment CyberVadis is an independent cybersecurity risk assessment platform widely used across global supply chains, particularly in healthcare, pharmaceuticals, and life sciences, to evaluate an organisation's information security posture against recognised industry frameworks such as ISO 27001, NIST, and GDPR-aligned controls. The assessment evaluates areas including governance, data protection, access control, asset management, third-party risk management, business continuity, and incident response. Assessments are scored on a 1,000-point scale and mapped to maturity bands (ranging from Basic to Mature to Advanced), with recognition levels of Bronze, Silver, Gold, and Platinum awarded based on the score achieved. A CyberVadis certification is increasingly sought by multinational customers, payers, hospital networks, and pharmaceutical partners as a pre-qualification requirement before onboarding vendors and service providers, particularly where sensitive patient and health data is handled. Significance for the Company and Stakeholders ● Regulatory and client trust: In the healthcare and medical services sector, demonstrable cybersecurity maturity is a material factor in client due diligence, hospital and insurer empanelment, and cross-border data-handling arrangements. ● Risk mitigation: An independent, externally validated assessment reduces the Company's exposure to data-breach, ransomware, and third-party supply-chain risk — risks that carry direct financial, reputational, and regulatory consequences for listed entities. ● Competitive differentiation: Gold-level certification distinguishes the Company in vendor empanelment processes where cybersecurity scorecards are increasingly a mandatory evaluation criterion. CIN: L33309MH2017PLC299748; Email Id: mm@qmsmas.com ● Governance signal to investors: The certification reflects the Board's and management's continued investment in information security governance, forming part of the Company's broader ESG and enterprise risk management framework. ● Business continuity: Strengthened controls around data protection and incident response reduce the likelihood of service disruption, which is particularly critical given the Company's role in the healthcare services value chain. Given the sensitivity of patient and healthcare data handled in the ordinary course of business, the Company views continued compliance with recognised cybersecurity assessment frameworks such as CyberVadis, ISO 27001, and applicable data protection regulations as an ongoing and material component of its risk management and corporate governance practices, and not as a one-time exercise. This disclosure is being made in the interest of transparency and in compliance with applicable disclosure requirements under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This is for your information and records. Thanking you, Yours truly, FOR QMS MEDICAL ALLIED SERVICES LIMITED TORAL BHADRA COMPANY SECRETARY AND COMPLIANCE OFFICER MEMBERSHIP NO.: A56927 DATE: AUGUST 19, 2026 PLACE: MUMBAI CIN: L33309MH2017PLC299748; Email Id: mm@qmsmas.com